Globalization and Innovation in the Indian Pharmaceutical Industry

Loitongbam, Bishwanjit Singh (2016): Globalization and Innovation in the Indian Pharmaceutical Industry.

Abstract

The changing global environment brings about new opportunities and new markets for domestic firms in developing countries. We examine the impacts of globalization and IPR protection on the innovation in the Indian pharmaceutical industry, using the firm-level panel data. This paper finds that there is a positive and highly significant level of foreign ownership effect on R&D activities. This indicates that there is technology spillover in the Indian pharmaceutical industry. TRIPS implementation has insignificant effects on R&D innovation. It is also found that exporting firms and firms with a higher productivity level are significantly more likely to carry out R&D activities.

• Item Type: MPRA Paper
• Language: English
• Keywords: Globalization, Foreign Ownership, Innovation, R&D
• Subjects: F - International Economics > F1 - Trade; F - International Economics > F1 - Trade > F14 - Empirical Studies of Trade; F - International Economics > F6 - Economic Impacts of Globalization

References

Aitken, Brain J. and Harrison A. E. (1999). Do Domestic Firms Benefit from Direct Foreign Investment? Evidence from Venezuela. The American Economic Review, Vol. 89, No. 3, pp. 605-618.

Ala, M. U. (2013). A Firm-level Analysis of the Vulnerability of the Bangladeshi Pharmaceutical Industry to the TRIPS Agreement: Implications for R&D Capability and Technology Transfer. Procedia Economics and Finance, Vol. 5, pp. 30 – 39.

Allred, B. and Park, W. (2007). Patent Rights and Innovative Activity: Evidence from National and Firm-level Data. Journal of Business International Studies, Vol. 38, No. 6, pp. 878-900.

Aw, B. Y., Roberts, M. J. & Winston, T. (2007). Export Market Participation, Investments in R&D and Worker Training, and the Evolution of Firm Productivity. The World Economy, Vol.30, No. 1, pp. 83–104.

Bedi, N., Bedi P.M.S. & Sooch, B.S. (2013). Patenting and R&D in Indian Pharmaceutical Industry: Post-TRIPS Scenario. Journal of Intellectual Property Rights, Vol 18, No.2, pp 105-110.

Branstetter, L. G., Fisman , R. and Foley, C. F. (2006). Do Stronger Intellectual Property Rights Increase International Technology Transfer? Empirical Evidence from U. S. Firm-Level Panel Data. The Quarterly Journal of Economics, Vol. 121, No. 1, pp. 321-349.

Branstetter, L., Fisman, R., Foley, C. F. & Saggi, K. (2011). Does Intellectual Property Rights Reform Spur Industrial Development? Journal of International Economics, Vol. 83, No. 1, pp. 27–36.

Cassiman, B. and Golovko, E. (2011). “Innovation and Internationalization Through Exports”. Journal of International Business Studies, Vol. 42, 56-75.

Chadha, A. (2009). TRIPs and Patenting Activity: Evidence from the Indian Pharmaceutical Industry. Economic Modelling, Vol. 26, No. 2, pp. 499-505.

Chaudhuri, S. (2007). Is Product Patent Protection Necessary in Developing Countries for Innovation? R&D by Indian Pharmaceutical Companies after TRIPs. Indian Institute of Management, Calcutta, Working Papers Series No. 614/ Sep. 2007.

Chaudhuri, S. (2011). Multinationals and Monopolies Pharmaceutical Industry in India after TRIPs. Indian Institute of Management, Calcutta, Working Papers Series No. 685/ Nov. 2011.

Chaudhuri, Sh., Goldberg, P.K. & Jia, P. (2006). Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India. The American Economic Review, Vol. 96, No. 5, pp. 1477-1514.

Coe, D.T. and Helpman, E. (1995). International R&D spillovers. European Economic Review, Vol. 39, No. 5, pp. 859-887.

Croix, S. &. (1996). Product Patent Reform and Its Impact on Korea’s Pharmaceutical Industry. International Economics Journal, Vol. 10, No. 1, pp.109-124.

Dinar, K. ( 2005). Learning to Innovate: The Indian Pharmaceutical Industry Response to Emerginf TRIPs Regime. DRUID Academy Winter 2005 PhD Conference.

Dinopoulos, E. and Segerstrom, P. (2010). Intellectual Property Rights, Multinational Firms and Economic Growth. Journal of Development Economics, Vol. 92, No. 1, pp. 13–27.

Eaton, J. and Kortum, S. (1996). Trade in Ideas Patenting and Productivity in the OECD. Journal of International Economics, Vol 40, No. 3-4, Page 251-278.

Feinberg, S.E. and Majumdar, S.K. (2001). Technology Spillovers from Foreign Direct Investment in the Indian Pharmaceutical Industry. Journal of International Business Studies, Vol. 32, No. 3, pp. 421-437.

Girma, S., Görg, H. and Hanley, A. (2008). R&D and Exporting: A Comparison of British and Irish Firms. Review of World Economics, Vol. 144, No. 4, pp. 750-773.

Greene, W. (2007). The Emergence of India’s Pharmaceutical Industry and Implications for the U.S. Generic Drug Market. Office of Economics Working Papers - U.S. International Trade Commission.

Griliches, Z. (1979). “Issues in Assessing the Contribution of R&D to Productivity Growth”. The Bell Journal of Economics, Vol.10, 92-116.

Griliches, Z. (1986). “ Productivity, R&D, and Basic Research at the Firm Level in the 1970s” . NBER Working Paper No. 1547.

Griliches, Z. (1992). “The Search for R&D Spillovers”. NBERWorking Paper No. 3768.

Griliches, Z. and Maisesse J. (1990). R&D and Productivity Growth: Comparing Japanese and U.S. Manufacturing Firms. NBER Working Paper No. 1778.

Grossman G.M. and Helpman, E. (1991). Endogenous Innovation in the Theory of Growth. The Journal of Economic Perspectives, Vol. 8, No. 1, pp. 23-44.

Grossman, G.M. and Helpman, E. (1990a). Comparative Advantage and Long-Run Growth. American Economic Review, Vol. 80, No. 4, pp. 796-815.

Grossman, G.M. and Helpman, E. (1990b). Trade, Innovation, and Growth. American Economic Review, Vol. 80, No. 2, pp. 86-91.

Guennif, S. & Ramani Sh. V. (2012). Explaining Divergence in Catching-up in Pharma Between India and Brazil using the NSI framework. Research Policy, Vol. 41, No. 2, pp. 430-441.

Haakonsson, S.J., Jensen, P.D.O. and Mudambi, S.M. (2013). A Co-evolutionary Perspective on the Drivers of International Sourcing of Pharmaceutical R&D to India. Journal of Economic Geography, Vol. 13, No.4, pp. 677-700.

Helpman, E. (1993). Innovation, Imitation, and Intellectual Property Rights. Econometrica, Vol. 61, No. 6, pp. 1247-80.

Iyer, C. G. (2012). Foreign Firms, Indian Multinationals and Spillovers in the Indian Pharmaceutical Industry. Indian Growth and Development Review, Vol. 5, No. 2, pp. 131-150.

Jha, R. (2007). Options for Indian Pharmaceutical Industry in the Challenging Environment. Economic and Political Weekly, Vol. 42, No. 39, pp. 3958-3967.

Jiatao, L. & Jing, Zh. (2003). Explaining the Growth of International R&D Alliances in China. Managerial and Decision Economics, Vol. 24, No. 2-3, pp. 101-115.

Kim, Y. K., Lee, K., Park,W. G. and Choo, K. (2012). Appropriate Intellectual Property Protection and Economic Growth in Countries at Different Levels of Development. Research Policy, Vol. 41, No. 2, pp. 358– 375.

Kiran, R. and Mishra, S. (2009b). Performance of the Indian Pharmaceutical Industry in Post-TRIPS Period: A Firm Level Analysis. International Review of Business Research Papers, Vol. 5, No. 6, pp. 148-160.

Kiran, R. and Mishra, S. (2009a). Changing Pragmatics of the Indian Pharmaceutical Industry in the Pre and Post TRIPS Period. International Journal of Business and Management, Vol. 4, No. 9, pp. 206-220.

Kyle, M. and McGahan, A. (2012). “Investments in Pharmaceuticals Before and After TRIPS ”. The Review of Economics and Statistics, Vol. 94, No. 4, pp. 1157-1172.

Lai, E. L. C. & Qiu, L.D. (2003). The North’s Intellectual Property Rights Standard for the South? Journal of International Economics, Vol 59., No. 1, pp. 183-209.

Lalitha, N. (2002). Indian Pharmaceutical Industry in WTO Regime: A SWOT Analysis. Economic and Political Weekly, Vol. 37, No. 34, pp. 3542-3555.

Levinsohn, J. & Petrin, A. (2003). Estimating Production Functions Using Inputs to Control for Unobservables. The Review of Economic Studies, Vol. 70, No. 2, pp. 317-341.

McCalman, P. (2001 ). Reaping What You Sow: An Empirical Analysis of International Patent Harmonization. Journal of International Economics,, Vol. 55, No.1, pp. 161-186.

Nadiri, M. I. (1993). Innovations and Technological Spillovers. Working Paper No. 4423, (Aug, 1993). http://www.nber.org/papers/w4423.

Nandkumar, A., Chatterjee, Ch. and Dhanaraj, Ch. (2011). Learning by Export: To Whom Does The Benefit Accrue? New Evidence From Indian Pharmaceutical Industry. SSRN Electronic Journal, https://www.researchgate.net/publication/228237749_Learning_by_Exporting_To_Whom_Does_the_Benefit_Accrue_New_Evidence_from_Indian_Pharmaceutical_Industry.

Niosi, J., Hanel P. and Reid, S. (2012). The International Diffusion of Biotechnology: The Arrival of Developing Countries. Journal of Evolutionary Economics, Vol. 22, No. 4, (Sep, 2012) pp. 767-783.

Pradhan, P. J. (2002). FDI Spillovers and Local Productivity Growth: Evidence from Indian Pharmaceutical Industry. ArthaVijnana, Vol. 54, No. 3-4, pp 317-332.

Pradhan, P. J. (2003). Liberalization, Firm Size and R&D performance: A Firm Level Study of Indian Pharmaceutical Industry. Journal of Indian School of Political Economy, Vol. 14, No. 4, pp. 647-666.

Pradhan, P. J. (2007). New Policy Regime and Small Pharmaceutical Firms in India. ISID Working Paper No 2007/02.http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1515675.

Qian, Y. (2007). Do National Patent Laws Stimulate Domestic Innovation in a Global Patenting Environment? A Cross-country Analysis of Pharmaceutical Patent Protection, 1978-2002. The Review of Economics and Statistics, Vol. 89, No. 3, pp. 436-453.

Saranga, H. and Phani, V. B. (2009). The Indian Pharmaceutical Industry – An Overview on Cost Efficiency” using DEA. The Journal of the International Transactions in Operational Research, Vol. 16, No. 1, pp. 109-13.

Sweet, C. M. and Maggio, D.S.E. (2015). Do Stronger Intellectual Property Rights Increase Innovation? World Development, Vol. 66, Feb, pp. 665–677.

Vita, G. D. (2013). The TRIPs Agreement and Technological Innovation. Journal of Policy Modeling, Vol. 35, No. 6, pp. 964–977.

Wakelin, K. (2001). Productivity Growth and R&D Expenditure in UK Manufacturing firms. Research Policy, Vol. 30, No. 7, pp. 1079–1090.

Wang, E. C. (2010). Determinants of R&D investment: The Extreme-Bounds-Analysis approach applied to 26 OECD countries. Research Policy, Vol. 39, No. 1, pp. 103–116.